A biotech company

Improving quality of life for osteoarthritis patients

PharmaLube is a biopharmaceutical company developing Lubrium™, a synthetic bottle-brush polymer, a high-performance lubricant that could be of use for the treatment of osteoarthritis, dry eye disease and other cosmetic and industrial applications.

Lubrium

Technology

A new approach in the treatment of osteoarthritis

Lubrium™ is a synthetic bottle-brush polymer which mimics and acts like the biologic glycoprotein lubricin, a natural-acting lubricant.

More info on our technology

Knee osteoarthritis

Opportunities

Osteoarthritis causes pain, stiffness and movement restrictions which reduces physical activities and quality of life for patients

Osteoarthritis affects more than 7 million people in Canada and nearly 80 million in the US.

Indications

Human

  • Osteoarthritis
  • Dry eye disease
  • Contact lenses
  • Surgical adhesions

Veterinary

  • Osteoarthritis - Dogs
  • Osteoarthritis - Horses

PIPELINE

Lubrium™ is presently in preclinical development for the treatment of osteoarthritis and dry eye disease

See clinical development program

Get PharmaLube news by email

© PharmaLube Technologies Inc. 2026

302-230, Sherbrooke Street East
Montreal (Quebec) H2X1E1
Canada